Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 181 (RNA5SP181) is a processed pseudogene in Homo sapiens derived from the 5S ribosomal RNA gene family[2][6][7]. Pseudogenes are genetic elements that resemble functional genes but have lost their protein-coding or functional RNA-coding ability, often as a result of mutations, truncations, or lack of regulatory features[8][6]. 5S rRNA itself is an integral part of the large ribosomal subunit, crucial for ribosomes and protein synthesis in all domains of life[1][3][5][7]. However, RNA5SP181 does not produce functional 5S rRNA and is not believed to contribute structurally or functionally to ribosome assembly or activity[2][7]. Most such pseudogenes are not transcribed, and if transcribed, they generally do not yield functional molecules or have established drug interactions or biomarker utility[4][8]. In rare cases, pseudogenes may act in gene regulation (e.g., via competing endogenous RNA mechanisms or small interfering RNAs), but there are no data implicating RNA5SP181 in such roles. Thus, it is not a therapeutic target and is categorized as a pseudogene with no established function or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 181 (RNA5SP181).